Exai Bio
is a California-based biotechnology company that develops oncRNA and AI-driven liquid biopsy technology for the treatment of cancer diagnosis... Read moreExai Bio
is a California-based biotechnology company that develops oncRNA and AI-driven liquid biopsy technology for the treatment of cancer diagnosis... Read more
News
Nov 21, 2024
Yahoo
Exai Bio: Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform
Apr 08, 2024
StreetInsider
Press Release: Exai : Exai Bio to Present New Breast Cancer Data at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Dec 06, 2023
Benzinga
Exai: Exai Bio's RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy, Overcoming Many Limitations of DNA-based Approaches
Sep 11, 2023
Acrofan
Exai: Exai Bio Presents Data Further Validating its Liquid Biopsy Platform at the 2023 World Conference on Lung Cancer
Jun 03, 2023
Acrofan
Exai: Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Apr 18, 2023
Acrofan
Exai: Exai Bio Presents New Non-Small Cell Lung Cancer Early Detection Data at the American Association for Cancer Research (AACR) 2023 Annual Meeting
Apr 01, 2023
Pharmabiz
Exai: Exai Bio, QLHC announce expanded participation in ISPY 2 trial to advance Exai's novel RNAbased liquid biopsy platform in breast cancer
Feb 02, 2023
StreetInsider
Press Release: Exai : Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team
Dec 06, 2022
Acrofan
Exai: Exai Bio's RNA-based Liquid Biopsy Platform Delivers Promising Data on Detecting Breast Cancer at its Earliest Stages
Sep 10, 2022
Daily Host News
Exai: Exai Bio Presents Data Demonstrating that its Novel RNA-based Liquid Biopsy Platform has Potential for Early Detection and Monitoring of Colorectal Cancer
Exai Bio Competitors
1
2
3
4
5
6
7
8
9
10